Home About ISR Investor Relations Media Room

Press release 2017-03-02

Uppdatering avseende ISR Holding ABs ansökan om upptagande till handel på Nasdaq First North

Files & documents

ISR pressmeddelande 2 mars 2017 (PDF)

Previous Next

Twitter ISR on Nasdaq

© ISR Immune System Regulation Holding AB (publ). All rights reserved.

Retzius väg 11

SE-171 65 Solna, Sweden

Email: info@israb.se

Phone: +46 705 42 79 39